Related Experiment Video
Updated: Jun 24, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Severe obesity among patients with left ventricular assist devices
Cathlyn K Medina1, Stephanie G Barnes2, G Michael Felker3
1Duke University School of Medicine, Durham, North Carolina.
Background:
Patients with obesity and advanced heart failure requiring left ventricular assist device (LVAD) support are more likely to experience LVAD complications and may be disproportionately Black and/or female when compared to patients without obesity. Among these patients, obesity may represent a barrier to transplant eligibility and a marker of inequity in heart transplantation and health outcomes in advanced heart failure.
Methods:
To better understand this issue at our institution, we examined our active LVAD cohort and found that almost one-third of all patients had severe obesity with BMI ≥ 35 kg/m2.
Results:
Patients with LVADs and severe obesity were significantly younger and more likely to self-identify as Black, and numerically more likely to be female.
Conclusion:
Weight management in this group represents a vital area for improved equity in health outcomes and barriers to heart transplantation.
Trial Registration:
NA.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Obesity
Pathophysiology of Heart Failure
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inotropic Agents

